

Hatteras Venture Partners has raised over $137.2 million for its sixth fund, according to an SEC filing. The target is $250 million. The North Carolina-based venture firm invests in biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine.
Source: SEC filing